Services
Therapeutic Development
Creating targeted treatments designed to improve patient outcomes and quality of life
Clinical Trials
Oncogenexe Biotech’s Clinical Trials service supports the design and execution of oncology-focused studies to evaluate safety, efficacy, and patient outcomes. Protocol_ PDAC_0_001 A multicentre open labelled randomized phase I dose escalation and expansion trial evaluating the safetyefficacy of a Bispecific/Trispecific Antibody Drug Conjugate (novel design), dosage formulation, Pharmacokinetic/Pharmacodynamic PK/PD analysis, safety evaluation and tolerability, and recommended Phase 2 dose, in participants stricken with Pancreatic Ductal Adenocarcinoma (PDAC), evaluating 3 pathways, the NFκB//NUAK1 (canonical, non-canonical), and the Phospho-inisotide Epidermal Growth Factor Receptor/Phospho-inisotide 3 Kinase, EGFR/PI3K/AKT/mTOR pathways
Patient Support
Providing comprehensive care and resources to patients during their treatment journey.
Mentorship Programmes - Medical and Scientific Life Science Fields
Specifically designed for aspiring molecular biology affiliated medical scientists and doctors (in the genetics, microbiology and biochemistry fields)